APO Research

APO RESEARCH · REPORT

Plasma Collection and Processing

Selected research

Market Outlook & Growth Opportunities

Global Plasma Collection and Processing Market Outlook and Growth Opportunities 2026

Market perspective

The global Plasma Collection and Processing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Plasma Collection and Processing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Plasma Collection and Processing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plasma Collection and Processing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Plasma Collection and Processing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Plasma Collection and Processing market include CSL Behring, Baxter, Grifols, Octapharma, Takeda, Octaphaarma, Kedrion, BPL and LFB Group, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Plasma Collection and Processing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Plasma Collection and Processing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Plasma Collection and Processing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Plasma Collection and Processing market.

Plasma Collection and Processing Segment by Company

CSL Behring

Baxter

Grifols

Octapharma

Takeda

Octaphaarma

Kedrion

BPL

LFB Group

Tiantan Biological Products

Shanghai RAAS Blood Products

Hualan Biological

Pacific Shuanglin Bio-pharmacy

China Biologic Products

Plasma Collection and Processing Segment by Type

Single Plasma Collection Station

Other

Plasma Collection and Processing Segment by Application

Albumin

Immunoglobulin

Coagulation Factor

Plasma Collection and Processing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Plasma Collection and Processing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Plasma Collection and Processing key companies, revenue, market share, and recent developments.

3. To split the Plasma Collection and Processing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Plasma Collection and Processing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Plasma Collection and Processing significant trends, drivers, influence factors in global and regions.

6. To analyze Plasma Collection and Processing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Collection and Processing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma Collection and Processing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Collection and Processing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plasma Collection and Processing industry.

Chapter 3: Detailed analysis of Plasma Collection and Processing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Plasma Collection and Processing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Plasma Collection and Processing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Plasma Collection and Processing Industry Trends Table 2. Plasma Collection and Processing Industry Drivers Table 3. Plasma Collection and Processing Industry Opportunities and Challenges Table 4. Plasma Collection and Processing Industry Restraints Table 5. Global Plasma Collection and Processing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Plasma Collection and Processing Revenue Share by Company (2021-2026) Table 7. Global Plasma Collection and Processing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Plasma Collection and Processing Key Company Manufacturing Base & Headquarters Table 9. Global Plasma Collection and Processing Company, Product Type & Application Table 10. Global Plasma Collection and Processing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Plasma Collection and Processing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Single Plasma Collection Station Table 15. Significant Companies of Other Table 16. Global Plasma Collection and Processing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Plasma Collection and Processing Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Plasma Collection and Processing Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Plasma Collection and Processing Sales Value Share by Type (2021-2026) Table 20. Global Plasma Collection and Processing Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Albumin Table 22. Significant Companies of Immunoglobulin Table 23. Significant Companies of Coagulation Factor Table 24. Global Plasma Collection and Processing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Plasma Collection and Processing Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Plasma Collection and Processing Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Plasma Collection and Processing Sales Value Share by Application (2021-2026) Table 28. Global Plasma Collection and Processing Sales Value Share by Application (2027-2032) Table 29. Global Plasma Collection and Processing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Plasma Collection and Processing Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Plasma Collection and Processing Sales Value Share by Region (2021-2026) Table 32. Global Plasma Collection and Processing Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Plasma Collection and Processing Sales Value Share by Region (2027-2032) Table 34. Global Plasma Collection and Processing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Plasma Collection and Processing Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Plasma Collection and Processing Sales Value Market Share by Country (2021-2026) Table 37. Global Plasma Collection and Processing Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Plasma Collection and Processing Sales Value Market Share by Country (2027-2032) Table 39. CSL Behring Company Information Table 40. CSL Behring Business Overview Table 41. CSL Behring Plasma Collection and Processing Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. CSL Behring Plasma Collection and Processing Product Portfolio Table 43. CSL Behring Recent Development Table 44. Baxter Company Information Table 45. Baxter Business Overview Table 46. Baxter Plasma Collection and Processing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Baxter Plasma Collection and Processing Product Portfolio Table 48. Baxter Recent Development Table 49. Grifols Company Information Table 50. Grifols Business Overview Table 51. Grifols Plasma Collection and Processing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Grifols Plasma Collection and Processing Product Portfolio Table 53. Grifols Recent Development Table 54. Octapharma Company Information Table 55. Octapharma Business Overview Table 56. Octapharma Plasma Collection and Processing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Octapharma Plasma Collection and Processing Product Portfolio Table 58. Octapharma Recent Development Table 59. Takeda Company Information Table 60. Takeda Business Overview Table 61. Takeda Plasma Collection and Processing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Takeda Plasma Collection and Processing Product Portfolio Table 63. Takeda Recent Development Table 64. Octaphaarma Company Information Table 65. Octaphaarma Business Overview Table 66. Octaphaarma Plasma Collection and Processing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Octaphaarma Plasma Collection and Processing Product Portfolio Table 68. Octaphaarma Recent Development Table 69. Kedrion Company Information Table 70. Kedrion Business Overview Table 71. Kedrion Plasma Collection and Processing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Kedrion Plasma Collection and Processing Product Portfolio Table 73. Kedrion Recent Development Table 74. BPL Company Information Table 75. BPL Business Overview Table 76. BPL Plasma Collection and Processing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. BPL Plasma Collection and Processing Product Portfolio Table 78. BPL Recent Development Table 79. LFB Group Company Information Table 80. LFB Group Business Overview Table 81. LFB Group Plasma Collection and Processing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. LFB Group Plasma Collection and Processing Product Portfolio Table 83. LFB Group Recent Development Table 84. Tiantan Biological Products Company Information Table 85. Tiantan Biological Products Business Overview Table 86. Tiantan Biological Products Plasma Collection and Processing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Tiantan Biological Products Plasma Collection and Processing Product Portfolio Table 88. Tiantan Biological Products Recent Development Table 89. Shanghai RAAS Blood Products Company Information Table 90. Shanghai RAAS Blood Products Business Overview Table 91. Shanghai RAAS Blood Products Plasma Collection and Processing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Shanghai RAAS Blood Products Plasma Collection and Processing Product Portfolio Table 93. Shanghai RAAS Blood Products Recent Development Table 94. Hualan Biological Company Information Table 95. Hualan Biological Business Overview Table 96. Hualan Biological Plasma Collection and Processing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Hualan Biological Plasma Collection and Processing Product Portfolio Table 98. Hualan Biological Recent Development Table 99. Pacific Shuanglin Bio-pharmacy Company Information Table 100. Pacific Shuanglin Bio-pharmacy Business Overview Table 101. Pacific Shuanglin Bio-pharmacy Plasma Collection and Processing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Pacific Shuanglin Bio-pharmacy Plasma Collection and Processing Product Portfolio Table 103. Pacific Shuanglin Bio-pharmacy Recent Development Table 104. China Biologic Products Company Information Table 105. China Biologic Products Business Overview Table 106. China Biologic Products Plasma Collection and Processing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. China Biologic Products Plasma Collection and Processing Product Portfolio Table 108. China Biologic Products Recent Development Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Plasma Collection and Processing Product Image Figure 2. Global Plasma Collection and Processing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasma Collection and Processing Market Size (2021-2032) & (US$ Million) Figure 4. Global Plasma Collection and Processing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Single Plasma Collection Station Image Figure 8. Other Image Figure 9. Global Plasma Collection and Processing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Plasma Collection and Processing Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Plasma Collection and Processing Sales Value Share by Type (2021-2032) Figure 12. Albumin Image Figure 13. Immunoglobulin Image Figure 14. Coagulation Factor Image Figure 15. Global Plasma Collection and Processing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Plasma Collection and Processing Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Plasma Collection and Processing Sales Value Share by Application (2021-2032) Figure 18. Global Plasma Collection and Processing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Plasma Collection and Processing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Plasma Collection and Processing Sales Value (2021-2032) & (US$ Million) Figure 21. North America Plasma Collection and Processing Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Plasma Collection and Processing Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Plasma Collection and Processing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Plasma Collection and Processing Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Plasma Collection and Processing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Plasma Collection and Processing Sales Value (2021-2032) & (US$ Million) Figure 27. South America Plasma Collection and Processing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Plasma Collection and Processing Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Plasma Collection and Processing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Plasma Collection and Processing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Single Plasma Collection Station
  • Other
Applications
  • Albumin
  • Immunoglobulin
  • Coagulation Factor
Companies covered
  • CSL Behring
  • Baxter
  • Grifols
  • Octapharma
  • Takeda
  • Octaphaarma
  • Kedrion
  • BPL
  • LFB Group
  • Tiantan Biological Products
  • Shanghai RAAS Blood Products
  • Hualan Biological
  • Pacific Shuanglin Bio-pharmacy
  • China Biologic Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Plasma Collection and Processing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Plasma Collection and Processing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Plasma Collection and Processing Market Dynamics
  1. 2.1 Plasma Collection and Processing Industry Trends
  2. 2.2 Plasma Collection and Processing Industry Drivers
  3. 2.3 Plasma Collection and Processing Industry Opportunities and Challenges
  4. 2.4 Plasma Collection and Processing Industry Restraints
3 Plasma Collection and Processing Market by Company
  1. 3.1 Global Plasma Collection and Processing Company Revenue Ranking in 2025
  2. 3.2 Global Plasma Collection and Processing Revenue by Company (2021-2026)
  3. 3.3 Global Plasma Collection and Processing Company Ranking (2024-2026)
  4. 3.4 Global Plasma Collection and Processing Company Manufacturing Base and Headquarters
  5. 3.5 Global Plasma Collection and Processing Company Product Type and Application
  6. 3.6 Global Plasma Collection and Processing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Plasma Collection and Processing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Plasma Collection and Processing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Plasma Collection and Processing Market by Type
  1. 4.1 Plasma Collection and Processing Type Introduction
  2. 4.1.1 Single Plasma Collection Station
  3. 4.1.2 Other
  4. 4.2 Global Plasma Collection and Processing Sales Value by Type
  5. 4.2.1 Global Plasma Collection and Processing Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Plasma Collection and Processing Sales Value by Type (2021-2032)
  7. 4.2.3 Global Plasma Collection and Processing Sales Value Share by Type (2021-2032)
5 Plasma Collection and Processing Market by Application
  1. 5.1 Plasma Collection and Processing Application Introduction
  2. 5.1.1 Albumin
  3. 5.1.2 Immunoglobulin
  4. 5.1.3 Coagulation Factor
  5. 5.2 Global Plasma Collection and Processing Sales Value by Application
  6. 5.2.1 Global Plasma Collection and Processing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Plasma Collection and Processing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Plasma Collection and Processing Sales Value Share by Application (2021-2032)
6 Plasma Collection and Processing Regional Value Analysis
  1. 6.1 Global Plasma Collection and Processing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Plasma Collection and Processing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Plasma Collection and Processing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Plasma Collection and Processing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Plasma Collection and Processing Sales Value (2021-2032)
  7. 6.3.2 North America Plasma Collection and Processing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Plasma Collection and Processing Sales Value (2021-2032)
  10. 6.4.2 Europe Plasma Collection and Processing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Plasma Collection and Processing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Plasma Collection and Processing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Plasma Collection and Processing Sales Value (2021-2032)
  16. 6.6.2 South America Plasma Collection and Processing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Plasma Collection and Processing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Plasma Collection and Processing Sales Value Share by Country, 2025 VS 2032
7 Plasma Collection and Processing Country-level Value Analysis
  1. 7.1 Global Plasma Collection and Processing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Plasma Collection and Processing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Plasma Collection and Processing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Plasma Collection and Processing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Plasma Collection and Processing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Plasma Collection and Processing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Plasma Collection and Processing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CSL Behring
  2. 8.1.1 CSL Behring Company Information
  3. 8.1.2 CSL Behring Business Overview
  4. 8.1.3 CSL Behring Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CSL Behring Plasma Collection and Processing Product Portfolio
  6. 8.1.5 CSL Behring Recent Developments
  7. 8.2 Baxter
  8. 8.2.1 Baxter Company Information
  9. 8.2.2 Baxter Business Overview
  10. 8.2.3 Baxter Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Baxter Plasma Collection and Processing Product Portfolio
  12. 8.2.5 Baxter Recent Developments
  13. 8.3 Grifols
  14. 8.3.1 Grifols Company Information
  15. 8.3.2 Grifols Business Overview
  16. 8.3.3 Grifols Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Grifols Plasma Collection and Processing Product Portfolio
  18. 8.3.5 Grifols Recent Developments
  19. 8.4 Octapharma
  20. 8.4.1 Octapharma Company Information
  21. 8.4.2 Octapharma Business Overview
  22. 8.4.3 Octapharma Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Octapharma Plasma Collection and Processing Product Portfolio
  24. 8.4.5 Octapharma Recent Developments
  25. 8.5 Takeda
  26. 8.5.1 Takeda Company Information
  27. 8.5.2 Takeda Business Overview
  28. 8.5.3 Takeda Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Takeda Plasma Collection and Processing Product Portfolio
  30. 8.5.5 Takeda Recent Developments
  31. 8.6 Octaphaarma
  32. 8.6.1 Octaphaarma Company Information
  33. 8.6.2 Octaphaarma Business Overview
  34. 8.6.3 Octaphaarma Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Octaphaarma Plasma Collection and Processing Product Portfolio
  36. 8.6.5 Octaphaarma Recent Developments
  37. 8.7 Kedrion
  38. 8.7.1 Kedrion Company Information
  39. 8.7.2 Kedrion Business Overview
  40. 8.7.3 Kedrion Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kedrion Plasma Collection and Processing Product Portfolio
  42. 8.7.5 Kedrion Recent Developments
  43. 8.8 BPL
  44. 8.8.1 BPL Company Information
  45. 8.8.2 BPL Business Overview
  46. 8.8.3 BPL Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BPL Plasma Collection and Processing Product Portfolio
  48. 8.8.5 BPL Recent Developments
  49. 8.9 LFB Group
  50. 8.9.1 LFB Group Company Information
  51. 8.9.2 LFB Group Business Overview
  52. 8.9.3 LFB Group Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 LFB Group Plasma Collection and Processing Product Portfolio
  54. 8.9.5 LFB Group Recent Developments
  55. 8.10 Tiantan Biological Products
  56. 8.10.1 Tiantan Biological Products Company Information
  57. 8.10.2 Tiantan Biological Products Business Overview
  58. 8.10.3 Tiantan Biological Products Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Tiantan Biological Products Plasma Collection and Processing Product Portfolio
  60. 8.10.5 Tiantan Biological Products Recent Developments
  61. 8.11 Shanghai RAAS Blood Products
  62. 8.11.1 Shanghai RAAS Blood Products Company Information
  63. 8.11.2 Shanghai RAAS Blood Products Business Overview
  64. 8.11.3 Shanghai RAAS Blood Products Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shanghai RAAS Blood Products Plasma Collection and Processing Product Portfolio
  66. 8.11.5 Shanghai RAAS Blood Products Recent Developments
  67. 8.12 Hualan Biological
  68. 8.12.1 Hualan Biological Company Information
  69. 8.12.2 Hualan Biological Business Overview
  70. 8.12.3 Hualan Biological Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hualan Biological Plasma Collection and Processing Product Portfolio
  72. 8.12.5 Hualan Biological Recent Developments
  73. 8.13 Pacific Shuanglin Bio-pharmacy
  74. 8.13.1 Pacific Shuanglin Bio-pharmacy Company Information
  75. 8.13.2 Pacific Shuanglin Bio-pharmacy Business Overview
  76. 8.13.3 Pacific Shuanglin Bio-pharmacy Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Pacific Shuanglin Bio-pharmacy Plasma Collection and Processing Product Portfolio
  78. 8.13.5 Pacific Shuanglin Bio-pharmacy Recent Developments
  79. 8.14 China Biologic Products
  80. 8.14.1 China Biologic Products Company Information
  81. 8.14.2 China Biologic Products Business Overview
  82. 8.14.3 China Biologic Products Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 China Biologic Products Plasma Collection and Processing Product Portfolio
  84. 8.14.5 China Biologic Products Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research